These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1226193)

  • 21. [Pregnancy and delivery in a woman with Wilson's disease (degeneratio hepatoleuticularis)].
    Pierzchała W; Zamłyński J; Rzempołuch J
    Pol Tyg Lek; 1994 Feb 21-28; 49(8-9):200-1. PubMed ID: 8084826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penicillamine hypersensitivity: successful desensitization of a patient with severe hepatic Wilson's disease.
    Chan CY; Baker AL
    Am J Gastroenterol; 1994 Mar; 89(3):442-3. PubMed ID: 8122662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of pennicillamine and zinc in the treatment of Wilson's disease.
    Farinati F; Cardin R; Mestriner C; Sturniolo GC; Naccarato R
    Am J Gastroenterol; 1995 Dec; 90(12):2264-5. PubMed ID: 8540540
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of Wilson's disease (hepatolenticular degeneration) with penicillamine and low-copper diet.
    Goldstein NP; Tauxe WN; McCall JT; Gross JB; Randall RV
    Trans Am Neurol Assoc; 1969; 94():34-7. PubMed ID: 5374484
    [No Abstract]   [Full Text] [Related]  

  • 25. Neuromuscular transmission and acetylcholine receptor antibodies in penicillamine-treated Wilson's disease patients.
    Anlar B; Kuruoğlu R; Varli K; Topçu M
    Muscle Nerve; 1996 May; 19(5):676-7. PubMed ID: 8618573
    [No Abstract]   [Full Text] [Related]  

  • 26. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 27. [Presymptomatic and hepatic forms of Wilson's disease in childhood. Long-term therapy with D-penicillamine].
    Kittoe K; Colombo JP
    Praxis; 1968 Dec; 57(49):1723-9. PubMed ID: 5756864
    [No Abstract]   [Full Text] [Related]  

  • 28. [Wilson's disease (hepatolenticular degeneration)].
    Ferrer S; Grismali J; Vergara F; Madrid R; Colombo M
    Rev Med Chil; 1968 Dec; 96(12):779-88. PubMed ID: 5732518
    [No Abstract]   [Full Text] [Related]  

  • 29. [Therapeutic effects of penicillamine on Wilson's disease].
    Takagi H; Yoshida K; Okamura S; Maehashi M
    Nihon Rinsho; 1965 Oct; 23(10):2038-44. PubMed ID: 5895380
    [No Abstract]   [Full Text] [Related]  

  • 30. [Laboratory changes and complications during long-term therapy of Wilson's disease using D-penicillamine].
    Hauftová D; Slavícek J; Hartl J; Seidlová V; Komenda S
    Vnitr Lek; 1970 Apr; 16(4):344-53. PubMed ID: 5443326
    [No Abstract]   [Full Text] [Related]  

  • 31. Elastosis perforans serpiginosa secondary to D-penicillamine treatment in a Wilson's disease patient.
    Deguti MM; Mucenic M; Cancado EL; Tietge UJ
    Am J Gastroenterol; 2002 Aug; 97(8):2153-4. PubMed ID: 12190204
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membranoproliferative glomerulonephritis in a patient with Wilson's disease.
    Ozçakar ZB; Ekim M; Ensari A; Kuloglu Z; Yüksel S; Acar B; Kirsaçlioglu C; Kansu A; Yalçinkaya F; Girgin N
    J Nephrol; 2006; 19(6):831-3. PubMed ID: 17173260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early onset of nephrotic syndrome after treatment with D-penicillamine in a patient with Wilson's disease.
    Siafakas CG; Jonas MM; Alexander S; Herrin J; Furuta GT
    Am J Gastroenterol; 1998 Dec; 93(12):2544-6. PubMed ID: 9860423
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Wilson's disease treated with penicillamine (author's transl)].
    Aksamija-Rizvić B
    Lijec Vjesn; 1976 Aug; 98(8):430-1. PubMed ID: 1004094
    [No Abstract]   [Full Text] [Related]  

  • 36. [Wilson's disease: hepatocerebral degeneration. 2. Clinical findings and therapy].
    Kunath B; Biesold D
    Dtsch Gesundheitsw; 1969 Jun; 24(25):1169-73. PubMed ID: 5376168
    [No Abstract]   [Full Text] [Related]  

  • 37. Wilson's disease in the Commonwealth of Dominica, a case report.
    Cooles P; Khosla D; Brathwaite A
    Trop Geogr Med; 1986 Mar; 38(1):84-6. PubMed ID: 3961914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Penicillamine treatment of Wilson's disease].
    Falkmer S; Samuelson G; Sjölin S
    Lakartidningen; 1969 May; 66(20):2097-105. PubMed ID: 5795695
    [No Abstract]   [Full Text] [Related]  

  • 39. Hepatolenticular degeneration (Wilson's disease).
    Wis Med J; 1970 Mar; 69(3):105-10. PubMed ID: 5434427
    [No Abstract]   [Full Text] [Related]  

  • 40. The mechanisms of penicillamine, trientine, and zinc in the treatment of Wilson's disease.
    Yarze JC
    Am J Gastroenterol; 1995 Jun; 90(6):1026. PubMed ID: 7771405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.